IRIDEX Share Holder Equity 2010-2024 | IRIX
IRIDEX share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
IRIDEX Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$10 |
| 2022 |
$17 |
| 2021 |
$23 |
| 2020 |
$17 |
| 2019 |
$23 |
| 2018 |
$30 |
| 2017 |
$31 |
| 2016 |
$39 |
| 2015 |
$34 |
| 2014 |
$34 |
| 2013 |
$26 |
| 2012 |
$22 |
| 2011 |
$22 |
| 2010 |
$19 |
| 2009 |
$15 |
IRIDEX Quarterly Share Holder Equity
(Millions of US $) |
| 2024-09-30 |
$3 |
| 2024-06-30 |
$4 |
| 2024-03-31 |
$6 |
| 2023-12-31 |
$10 |
| 2023-09-30 |
$12 |
| 2023-06-30 |
$13 |
| 2023-03-31 |
$16 |
| 2022-12-31 |
$17 |
| 2022-09-30 |
$18 |
| 2022-06-30 |
$19 |
| 2022-03-31 |
$21 |
| 2021-12-31 |
$23 |
| 2021-09-30 |
$25 |
| 2021-06-30 |
$27 |
| 2021-03-31 |
$26 |
| 2020-12-31 |
$17 |
| 2020-09-30 |
$17 |
| 2020-06-30 |
$19 |
| 2020-03-31 |
$21 |
| 2019-12-31 |
$23 |
| 2019-09-30 |
$24 |
| 2019-06-30 |
$26 |
| 2019-03-31 |
$27 |
| 2018-12-31 |
$30 |
| 2018-09-30 |
$33 |
| 2018-06-30 |
$24 |
| 2018-03-31 |
$27 |
| 2017-12-31 |
$31 |
| 2017-09-30 |
$35 |
| 2017-06-30 |
$38 |
| 2017-03-31 |
$40 |
| 2016-12-31 |
$39 |
| 2016-09-30 |
$35 |
| 2016-06-30 |
$35 |
| 2016-03-31 |
$34 |
| 2015-12-31 |
$34 |
| 2015-09-30 |
$33 |
| 2015-06-30 |
$33 |
| 2015-03-31 |
$34 |
| 2014-12-31 |
$34 |
| 2014-09-30 |
$26 |
| 2014-06-30 |
$26 |
| 2014-03-31 |
$27 |
| 2013-12-31 |
$26 |
| 2013-09-30 |
$25 |
| 2013-06-30 |
$24 |
| 2013-03-31 |
$23 |
| 2012-12-31 |
$22 |
| 2012-09-30 |
$24 |
| 2012-06-30 |
$25 |
| 2012-03-31 |
$24 |
| 2011-12-31 |
$22 |
| 2011-09-30 |
$22 |
| 2011-06-30 |
$21 |
| 2011-03-31 |
$20 |
| 2010-12-31 |
$19 |
| 2010-09-30 |
$18 |
| 2010-06-30 |
$17 |
| 2010-03-31 |
$16 |
| 2009-12-31 |
$15 |
| 2009-09-30 |
$14 |
| 2009-06-30 |
$14 |
| 2009-03-31 |
$12 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.028B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
